Drug Benefit List - April 2009
08:00 ANTI-INFECTIVE AGENTS
08:08.00 ANTHELMINTICS
MEBENDAZOLE
- 100MG Tablet
- 00556734 VERMOX JNO
PYRANTEL PAMOATE
- 50MG/ML Suspension
- 01944355 COMBANTRIN PFI
- 125MG Tablet
- 01944363 COMBANTRIN PFI
PYRVINIUM PAMOATE
- 10MG/ML Suspension
- 02019809 VANQUIN WLA
08:12.06 CEPHALOSPORINS
CEFACLOR
- 250MG Capsule
- 02230263 APO-CEFACLOR APX
- 00465186 CECLOR PHH
- 02177633 DOM-CEFACLOR DPC
- 02231691 NOVO-CEFACLOR NOP
- 02231432 NU-CEFACLOR NXP
- 02238200 PDL-CEFACLOR PDL
- 02237729 SCHEIN-CEFACLOR SCN
- 500MG Capsule
- 02230264 APO-CEFACLOR APX
- 00465194 CECLOR PHH
- 02177641 DOM-CEFACLOR DPC
- 02231693 NOVO-CEFACLOR NOP
- 02231433 NU-CEFACLOR NXP
- 02238201 PDL-CEFACLOR PDL
- 02237730 SCHEIN-CEFACLOR SCN
- 25MG/ML Suspension
- 02237500 APO-CEFACLOR APX
- 00465208 CECLOR PHH
- 02177668 DOM-CEFACLOR DPC
- 02238202 PDL-CEFACLOR PDL
- 50MG/ML Suspension
- 02237501 APO-CEFACLOR APX
- 00465216 CECLOR PHH
- 02177676 DOM-CEFACLOR DPC
- 02238203 PDL-CEFACLOR PDL
- 75MG/ML Suspension
- 02237502 APO-CEFACLOR APX
- 00832804 CECLOR
BID PHH
- 02177684 DOM-CEFACLOR DPC
- 02238204 PDL-CEFACLOR PDL
CEFADROXIL
- 500MG Capsule
- 02240774 APO-CEFADROXIL APX
- 00507245 DURICEF BMS
- 02235134 NOVO-CEFADROXIL NOP
- 02311062 PRO-CEFADROXIL PDL
CEFIXIME
- 20MG/ML Suspension
- 00868965 SUPRAX SAC
- 400MG Tablet
- 00868981 SUPRAX SAC
CEFPROZIL
- 25MG/ML Suspension
- 02293943 APO-CEFPROZIL APX
- 02163675 CEFZIL BMS
- 02303426 SANDOZ
CEFPROZIL SDZ
- 50MG/ML Suspension
- 02293951 APO-CEFPROZIL APX
- 02163683 CEFZIL BMS
- 02293579 RAN-CEFPROZIL RBY
- 02303434 SANDOZ
CEFPROZIL SDZ
- 250MG Tablet
- 02292998 APO-CEFPROZIL APX
- 02163659 CEFZIL BMS
- 02293528 RAN-CEFPROZIL RBY
- 02302179 SANDOZ
CEFPROZIL SDZ
- 500MG Tablet
- 02293005 APO-CEFPROZIL APX
- 02163667 CEFZIL BMS
- 02293536 RAN-CEFPROZIL RBY
- 02302187 SANDOZ
CEFPROZIL SDZ
CEFUROXIME AXETIL
- 25MG/ML Suspension
- 02212307 CEFTIN GSK
- 250MG Tablet
- 02244393 APO-CEFUROXIME APX
- 02212277 CEFTIN GSK
- 02242656 RATIO-CEFUROXIME RPH
- 500MG Tablet
- 02244394 APO-CEFUROXIME APX
- 02212285 CEFTIN GSK
- 02311453 PRO-CEFUROXIME PDL
- 02242657 RATIO-CEFUROXIME RPH
CEPHALEXIN
- 250MG Capsule
- 00342084 NOVO-LEXIN NOP
- 500MG Capsule
- 00342114 NOVO-LEXIN NOP
- 25MG/ML Suspension
- 02177862 DOM-CEPHALEXIN DPC
- 00342106 NOVO-LEXIN NOP
- 50MG/ML Suspension
- 02177870 DOM-CEPHALEXIN DPC
- 00342092 NOVO-LEXIN NOP
- 250MG Tablet
- 00768723 APO-CEPHALEX APX
- 02177846 DOM-CEPHALEXIN DPC
- 00583413 NOVO-LEXIN NOP
- 00865877 NU-CEPHALEX NXP
- 00828858 PDL-CEPHALEXIN PDL
- 02177781 PMS-CEPHALEXIN PMS
- 500MG Tablet
- 00768715 APO-CEPHALEX APX
- 02177854 DOM-CEPHALEXIN DPC
- 00583421 NOVO-LEXIN NOP
- 00865885 NU-CEPHALEX NXP
- 00828866 PDL-CEPHALEXIN PDL
- 02177803 PMS-CEPHALEXIN PMS
08:12.12 MACROLIDES
AZITHROMYCIN
- 20MG/ML Suspension
- 02315157 NOVO-AZITHROMYCIN NOP
- 02274388 PMS-AZITHROMYCIN PMS
- 02223716 ZITHROMAX PFI
- 40MG/ML Suspension
- 02315165 NOVO-AZITHROMYCIN NOP
- 02274396 PMS-AZITHROMYCIN PMS
- 02223724 ZITHROMAX PFI
- 250MG Tablet
- 02247423 APO-AZITHROMYCIN APX
- 02255340 CO-AZITHROMYCIN COB
- 02278359 GEN-AZITHROMYCIN GEN
- 02267845 NOVO-AZITHROMYCIN NOP
- 02261634 PMS-AZITHROMYCIN PMS
- 02310600 PRO-AZITHROMYCIN PDL
- 02275287 RATIO-AZITHROMYCIN RPH
- 02275309 RIVA-AZITHROMYCIN RIV
- 02265826 SANDOZ-AZITHROMYCIN SDZ
- 02212021 ZITHROMAX PFI
- 600MG Tablet
- 02256088 CO-AZITHROMYCIN COB
- 02261642 PMS-AZITHROMYCIN PMS
- 02275317 RIVA-AZITHROMYCIN RIV
- 02231143 ZITHROMAX PFI
CLARITHROMYCIN
- 500MG Extended Release Tablet
- 02244756 BIAXIN
XL ABB
- 250MG Film Coated Tablet
- 02274744 APO-CLARITHROMYCIN APX
- 01984853 BIAXIN ABB
- 02248856 GEN-CLARITHROMYCIN GEN
- 02247573 PMS-CLARITHROMYCIN PMS
- 02247818 RATIO-CLARITHROMYCIN RPH
- 02266539 SANDOZ-CLARITHROMYCIN RHO
- 500MG Film Coated Tablet
- 02266547 SANDOZ-CLARITHROMYCIN RHO
- 02274752 APO-CLARITHROMYCIN APX
- 02126710 BIAXIN ABB
- 02248857 GEN-CLARITHROMYCIN GEN
- 02247574 PMS-CLARITHROMYCIN PMS
- 02247819 RATIO-CLARITHROMYCIN RPH
- 25MG/ML Suspension
- 02146908 BIAXIN ABB
- 50MG/ML Suspension
- 02244641 BIAXIN ABB
ERYTHROMYCIN
- 250MG Enteric Coated Capsule
- 00726672 APO-ERYTHRO APX
- 00607142 ERYC PFI
- 333MG Enteric Coated Capsule
- 01925938 APO-ERYTHRO APX
- 333MG Enteric Coated Tablet
- 00873454 ERYC PFI
- 250MG Tablet
- 00682020 APO-ERYTHRO
BASE APX
ERYTHROMYCIN ESTOLATE
- 25MG/ML Suspension
- 00021172 NOVO-RYTHRO
ESTOLATE NOP
- 50MG/ML Suspension
- 00262595 NOVO-RYTHRO
ESTOLATE NOP
ERYTHROMYCIN ETHYLSUCCINATE
- 40MG/ML Suspension
- 00605859 NOVO-RYTHRO
ETHYLSUCCINATE NOP
- 80MG/ML Suspension
- 00652318 NOVO-RYTHRO
ETHYLSUCCINATE NOP
- 600MG Tablet
- 00637416 APO-ERYTHRO-S APX
- 00583782 EES-600 ABB
- 00704377 ERYTHRO-ES PDL
ERYTHROMYCIN STEARATE
- 250MG Tablet
- 00545678 APO-ERYTHRO-S APX
- 00563854 ERYTHROMYCIN PDL
- 02051850 NU-ERYTHROMYCIN
S NXP
- 500MG Tablet
- 00688568 APO-ERYTHRO
S APX
- 00704393 ERYTHRO PDL
08:12.16 PENICILLINS
AMOXICILLIN
- 250MG Capsule
- 00628115 APO-AMOXI APX
- 02238171 GEN-AMOXICILLIN GEN
- 02239761 MED-AMOXICILLIN MEC
- 00406724 NOVAMOXIN NOP
- 00865567 NU-AMOXI NXP
- 02229584 PENTA-AMOXICILLIN PEN
- 02230243 PMS-AMOXICILLIN PMS
- 00644307 PRO-AMOX PDL
- 02241826 SCHEIN-AMOXICILLIN SCN
- 500MG Capsule
- 00628123 APO-AMOXI APX
- 02238172 GEN-AMOXICILLIN GEN
- 02239762 MED-AMOXICILLIN MEC
- 00406716 NOVAMOXIN NOP
- 00865575 NU-AMOXI NXP
- 02233017 PENTA-AMOXICILLIN PEN
- 02230244 PMS-AMOXICILLIN PMS
- 00644315 PRO-AMOX PDL
- 02241827 SCHEIN-AMOXICILLIN SCN
- 125MG Chewable Tablet
- 02036347 NOVAMOXIN NOP
- 250MG Chewable Tablet
- 02036355 NOVAMOXIN NOP
- 25MG/ML Suspension
- 00628131 APO-AMOXI APX
- 00452149 NOVAMOXIN NOP
- 01934171 NOVAMOXIN
SUGAR REDUCED NOP
- 00865540 NU-AMOXI NXP
- 02229582 PENTA-AMOXICILLIN PEN
- 02230245 PMS-AMOXICILLIN PMS
- 00644323 PRO-AMOX PDL
- 50MG/ML Suspension
- 00628158 APO-AMOXI APX
- 00452130 NOVAMOXIN NOP
- 01934163 NOVAMOXIN
SUGAR REDUCED NOP
- 00865559 NU-AMOXI NXP
- 02229583 PENTA-AMOXICILLIN PEN
- 02230246 PMS-AMOXICILLIN PMS
- 00644331 PRO-AMOX PDL
AMOXICILLIN, CLAVULANIC ACID
- 25MG & 6.25MG/ML Suspension
- 02243986 APO-AMOXI
CLAV APX
- 01916882 CLAVULIN-F
125 GSK
- 40MG & 5.7MG/ML Suspension
- 02288559 APO-AMOXI
CLAV APX
- 02238831 CLAVULIN
200 GSK
- 50MG & 12.5MG/ML Suspension
- 02243987 APO-AMOXI
CLAV APX
- 01916874 CLAVULIN-F
250 GSK
- 80MG & 11.4MG/ML Suspension
- 02238830 CLAVULIN
400 GSK
- 250MG & 125MG Tablet
- 02243350 APO-AMOXI
CLAV APX
- 500MG & 125MG Tablet
- 02243351 APO-AMOXI
CLAV APX
- 01916858 CLAVULIN-F GSK
- 02243771 RATIO-ACLAVULANATE RPH
- 875MG & 125MG Tablet
- 02245623 APO-AMOXI
CLAV APX
- 02238829 CLAVULIN GSK
- 02248138 NOVO-CLAVAMOXIN NOP
- 02247021 RATIO-ACLAVULANATE RPH
AMPICILLIN
- 250MG Capsule
- 00020877 NOVO-AMPICILLIN NOP
- 500MG Capsule
- 00020885 NOVO-AMPICILLIN NOP
- 25MG/ML Suspension
- 00603260 APO-AMPICILLIN APX
- 00717495 NU-AMPI NXP
- 50MG/ML Suspension
- 00603287 APO-AMPICILLIN APX
- 00717649 NU-AMPI NXP
- 02043203 PENBRITIN WAY
CLOXACILLIN
- 250MG Capsule
- 00618292 APO-CLOXI APX
- 02069660 CLOXACILLINE PRO
- 00337765 NOVO-CLOXIN NOP
- 00717584 NU-CLOXI NXP
- 500MG Capsule
- 00618284 APO-CLOXI APX
- 02069679 CLOXACILLINE PRO
- 00337773 NOVO-CLOXIN NOP
- 00717592 NU-CLOXI NXP
- 25MG/ML Suspension
- 00644633 APO-CLOXI APX
- 00337757 NOVO-CLOXIN NOP
- 00717630 NU-CLOXI NXP
PENICILLIN V BENZATHINE
- 36MG/ML Suspension
- 02229618 PEN
VEE PED
- 60MG/ML Suspension
- 02229617 PEN
VEE PED
PENICILLIN V POTASSIUM
- 25MG/ML Suspension
- 00642223 APO-PEN
VK APX
- 60MG/ML Suspension
- 00642231 APO-PEN
VK APX
- 00391603 NOVO-PEN
VK NOP
- 300MG Tablet
- 00642215 APO-PEN
VK APX
- 00021202 NOVO-PEN
VK NOP
- 00717568 NU-PEN
VK NXP
- 00468029 PENICILLINE
V PDL
PIVAMPICILLIN
- 35MG/ML Suspension
- 00582239 PONDOCILLIN LEO
- 500MG Tablet
- 00582247 PONDOCILLIN LEO
PIVMECILLINAM HCL
- 200MG Tablet
- 00657212 SELEXID LEO
08:12.18 QUINOLONES
CIPROFLOXACIN HCL
- 250MG Tablet
- 02229521 APO-CIPROFLOX APX
- 02155958 CIPRO BAY
- 02251752 CIPROFLOXCIN PDL
- 02247339 CO-CIPROFLOXACIN COB
- 02251272 DOM-CIPROFLOXACIN DPC
- 02245647 GEN-CIPROFLOXACIN GEN
- 02161737 NOVO-CIPROFLOXACIN NOP
- 02249634 NU-CIPROFLOXACIN NXP
- 02251310 PHL-CIPROFLOXACIN PHH
- 02248437 PMS-CIPROFLOXACIN PMS
- 02249960 PREM-CIPROFLOXACIN PRE
- 02317796 PRO-CIPROFLOXACIN PDL
- 02303728 RAN-CIPROFLOX RBY
- 02267934 RAN-CIPROFLOXACIN RBY
- 02246825 RATIO-CIPROFLOXACIN RPH
- 02251221 RIVA-CIPROFLOXACIN RIV
- 02248756 SANDOZ-CIPROFLOXACIN SDZ
- 02266962 TARO-CIPROFLOXACIN TAR
- 500MG Tablet
- 02229522 APO-CIPROFLOX APX
- 02155966 CIPRO BAY
- 02251760 CIPROFLOXACIN PDL
- 02247340 CO-CIPROFLOXACIN COB
- 02251280 DOM-CIPROFLOXACIN DPC
- 02245648 GEN-CIPROFLOXACIN GEN
- 02161745 NOVO-CIPROFLOXACIN NOP
- 02249642 NU-CIPROFLOXACIN NXP
- 02251329 PHL-CIPROFLOXACIN PHH
- 02248438 PMS-CIPROFLOXACIN PMS
- 02249979 PREM-CIPROFLOXACIN PRE
- 02317818 PRO-CIPROFLOXACIN PDL
- 02303736 RAN-CIPROFLOX RBY
- 02267942 RAN-CIPROFLOXACIN RBY
- 02246826 RATIO-CIPROFLOXACIN RPH
- 02248757 RHOXAL-CIPROFLOXACIN RHO
- 02251248 RIVA-CIPROFLOXACIN RIV
- 02266970 TARO-CIPROFLOXACIN TAR
- 750MG Tablet
- 02229523 APO-CIPROFLOX APX
- 02155974 CIPRO BAY
- 02251779 CIPROFLOXACIN PDL
- 02247341 CO-CIPROFLOXACIN COB
- 02251299 DOM-CIPROFLOXACIN DPC
- 02245649 GEN-CIPROFLOXACIN GEN
- 02161753 NOVO-CIPROFLOXACIN NOP
- 02249650 NU-CIPROFLOXACIN NXP
- 02251337 PHL-CIPROFLOXACIN PHH
- 02248439 PMS-CIPROFLOXACIN PMS
- 02249987 PREM-CIPROFLOXACIN PRE
- 02303744 RAN-CIPROFLOX RBY
- 02267950 RAN-CIPROFLOXACIN RBY
- 02246827 RATIO-CIPROFLOXACIN RPH
- 02248758 RHOXAL-CIPROFLOXACIN RHO
- 02251256 RIVA-CIPROFLOXACIN RIV
NALIDIXIC ACID
- 500MG Tablet
- 02017687 NEGGRAM SAC
NORFLOXACIN
- 400MG Tablet
- 02229524 APO-NORFLOX APX
- 02269627 CO-NORFLOXACIN COB
- 02237682 NOVO-NORFLOXACIN NOP
- 02239670 PDL-NORFLOXACINE PDL
- 02246596 PMS-NORFLOXACIN PMS
- 02241483 RIVA-NORFLOXACIN RIV
- 02301504 RIVA-NORFLOXACIN RIV
OFLOXACIN
- 200MG Tablet
- 02231529 APO-OFLOX APX
- 02243474 NOVO-OFLOXACIN NOP
- 300MG Tablet
- 02231531 APO-OFLOX APX
- 02243475 NOVO-OFLOXACIN NOP
- 400MG Tablet
- 02231532 APO-OFLOX APX
- 02243476 NOVO-OFLOXACIN NOP
08:12.20 SULFONAMIDES
SULFAMETHOXAZOLE
- 500MG Tablet
- 00421480 APO-SULFAMETHOXAZOLE APX
SULFAMETHOXAZOLE, TRIMETHOPRIM
- 40MG & 8MG/ML Suspension
- 00846465 APO-SULFATRIM APX
- 00726540 NOVO-TRIMEL NOP
- 00865753 NU-COTRIMOX NXP
- 100MG & 20MG Tablet
- 00445266 APO-SULFATRIM
PED APX
- 400MG & 80MG Tablet
- 00445274 APO-SULFATRIM APX
- 00510637 NOVO-TRIMEL NOP
- 00865710 NU-COTRIMOX NXP
- 00512516 PROTRIN PDL
- 800MG & 160MG Tablet
- 00445282 APO-SULFATRIM
DS APX
- 00510645 NOVO-TRIMEL
DS NOP
- 00865729 NU-COTRIMOX
DS NXP
- 00512524 PROTRIN
DF PRO
SULFASALAZINE
- 500MG Enteric Coated Tablet
- 00598488 PMS-SULFASALAZINE PMS
- 02064472 SALAZOPYRIN PFI
- 500MG Tablet
- 00598461 PMS-SULFASALAZINE PMS
- 02064480 SALAZOPYRIN PFI
08:12.24 TETRACYCLINES
DOXYCYCLINE
- 100MG Capsule
- 00740713 APO-DOXY APX
- 00817120 DOXYCIN RIV
- 00742562 DOXYCYCLINE PDL
- 00725250 NOVO-DOXYLIN NOP
- 02044668 NU-DOXYCYCLINE NXP
- 02289539 PMS-DOXYCYCLINE PMS
- 02093103 RATIO-DOXYCYCLINE RPH
- 100MG Tablet
- 00874256 APO-DOXY APX
- 00860751 DOXYCIN RIV
- 00887064 DOXYTAB PDL
- 02158574 NOVO-DOXYLIN NOP
- 02044676 NU-DOXYCYCLINE NXP
- 02289466 PMS-DOXYCYCLINE PMS
- 02091232 RATIO-DOXYCYCLINE RPH
- 00578452 VIBRA-TABS PFI
MINOCYCLINE HCL
Limited use benefit (prior approval required).
For:
- patients who cannot tolerate other tetracyclines.
- patients with severe widespread acne who have failed on tetracycline.
- 50MG Capsule
- 02084090 APO-MINOCYCLINE APX
- 02239667 DOM-MINOCYCLINE DPC
- 02237875 MED-MINOCYCLINE MEC
- 02173514 MINOCIN STI
- 02108143 NOVO-MINOCYCLINE NOP
- 02153394 PDL-MINOCYCLINE PDL
- 02294419 PMS-MINOCYCLINE PMS
- 02239238 PMS-MINOCYCLINE PMS
- 01914138 RATIO-MINOCYCLINE RPH
- 02242080 RIVA-MINOCYCLINE RIV
- 02237313 SANDOZ-MINOCYCLINE SDZ
- 100MG Capsule
- 02084104 APO-MINOCYCLINE APX
- 02239668 DOM-MINOCYCLINE DPC
- 02237876 MED-MINOCYCLINE MEC
- 02173506 MINOCIN STI
- 02239982 MINOCYCLINE IVX
- 02108151 NOVO-MINOCYCLINE NOP
- 02154366 PDL-MINOCYCLINE PDL
- 02294427 PMS-MINOCYCLINE PMS
- 02239239 PMS-MONOCYCLINE PMS
- 01914146 RATIO-MINOCYCLINE RPH
- 02242081 RIVA-MINOCYCLINE RIV
- 02237314 SANDOZ-MINOCYCLINE SDZ
TETRACYCLINE HCL
- 250MG Capsule
- 00580929 APO-TETRA APX
- 00156744 TETRACYCLINE PRO
- 250MG Tablet
- 00717606 NU-TETRA NXP
08:12.28 MISCELLANEOUS ANTIBIOTICS
CLINDAMYCIN HCL
- 150MG Capsule
- 02245232 APO-CLINDAMYCIN APX
- 02248525 CLINDAMYCINE PDL
- 00030570 DALACIN
C PFI
- 02258331 GEN-CLINDAMYCIN GEN
- 02241709 NOVO-CLINDAMYCIN NOP
- 02294826 PMS-CLINDAMYCIN PMS
- 02130033 RATIO-CLINDAMYCIN RPH
- 02242409 RIVA-CLINDAMYCIN RIV
- 300MG Capsule
- 02245233 APO-CLINDAMYCIN APX
- 02248526 CLINDAMYCINE PDL
- 02182866 DALACIN
C PFI
- 02258358 GEN-CLINDAMYCIN GEN
- 02241710 NOVO-CLINDAMYCIN NOP
- 02294834 PMS-CLINDAMYCIN PMS
- 02192659 RATIO-CLINDAMYCIN RPH
- 02242410 RIVA-CLINDAMYCIN RIV
CLINDAMYCIN PALMITATE HCL
- 15MG/ML Solution
- 00225851 DALACIN
C PFI
FUSIDATE SODIUM
- 250MG Tablet
- 01934252 FUCIDIN
FC LEO
LINEZOLID
Limited use benefit (prior approval required).
Tablets:
For treatment of proven vancomycin-resistant enterococci (VRE) infections when
other antibiotics are not available, and for the treatment of proven Methicillin-Resistant
Staphylococcus aureus (MRSA) infections in patients who cannot tolerate or
who had an idiosyncratic reaction with Vancomycin.
I.V. solution:
When linezolid cannot be administered orally in the above mentioned situations.
- 2MG/ML Injection
- 02243685 ZYVOXAM PFI
- 600MG Tablet
- 02243684 ZYVOXAM PFI
08:14.04 ALLYLAMINES
TERBINAFINE HCL
- 250MG Tablet
- 02239893 APO-TERBINAFINE APX
- 02254727 CO-TERBINAFINE COB
- 02242503 GEN-TERBINAFINE GEN
- 02031116 LAMISIL NVR
- 02240346 NOVO-TERBINAFINE NOP
- 02248845 NU-TERBINAFINE NXP
- 02240807 PMS-TERBINAFINE PMS
- 02262924 RIVA-TERBINAFINE RIV
- 02262177 SANDOZ-TERBINAFINE SDZ
08:14.08 AZOLES
FLUCONAZOLE
- 150MG Capsule
- 02241895 APO-FLUCONAZOLE APX
- 02141442 DIFLUCAN PFI
- 02245697 GEN-FLUCONAZOLE GEN
- 02243645 NOVO-FLUCONAZOLE NOP
- 02246620 PMS-FLUCONAZOLE PMS
- 02282348 PMS-FLUCONAZOLE PMS
- 02310694 PRO-FLUCONAZOLE PDL
- 02255510 RIVA-FLUCONAZOLE RIV
- 10MG/ML Suspension
- 02024152 DIFLUCAN PFI
- 50MG Tablet
- 02237370 APO-FLUCONAZOLE APX
- 00891800 DIFLUCAN PFI
- 02245292 GEN-FLUCONAZOLE GEN
- 02236978 NOVO-FLUCONAZOLE NOP
- 02245643 PMS-FLUCONAZOLE PMS
- 02249294 TARO-FLUCONAZOLE TAR
- 100MG Tablet
- 02237371 APO-FLUCONAZOLE APX
- 02245293 GEN-FLUCONAZOLE GEN
- 02236979 NOVO-FLUCONAZOLE NOP
- 02245644 PMS-FLUCONAZOLE PMS
- 02310686 PRO-FLUCONAZOLE PDL
- 02271516 RIVA-FLUCONAZOLE RIV
- 02249308 TAR0-FLUCONAZOLE TAR
ITRACONAZOLE
- 100MG Capsule
- 02047454 SPORANOX JNO
- 10MG/ML Solution
- 02231347 SPORANOX JNO
KETOCONAZOLE
- 200MG Tablet
- 02237235 APO-KETOCONAZOLE APX
- 02231061 NOVO-KETOCONAZOLE NOP
- 02122197 NU-KETOCON NXP
VORICONAZOLE
Limited use benefit (prior approval required).
For the treatment of:
- patients with invasive aspergillosis.
- culture proven invasive candidiasis with documented resistance to fluconazole.
- 50MG Tablet
- 02256460 VFEND PFI
- 200MG Tablet
- 02256479 VFEND PFI
08:14.28 POLYENES
NYSTATIN
- 100,000U/ML Suspension
- 02125145 DOM-NYSTATIN DPC
- 00792667 PMS-NYSTATIN PMS
- 02194201 RATIO-NYSTATIN RPH
- 500,000U Tablet
- 02194198 RATIO-NYSTATIN RPH
08:16.04 ANTITUBERCULOSIS AGENTS
ETHAMBUTOL HCL
- 100MG Tablet
- 00247960 ETIBI VAE
- 400MG Tablet
- 00247979 ETIBI VAE
ISONIAZID
- 10MG/ML Syrup
- 00265500 ISOTAMINE VAE
- 00577812 PMS-ISONIAZID PMS
- 50MG Tablet
- 00577782 PMS-ISONIAZID PMS
- 300MG Tablet
- 00272655 ISOTAMINE VAE
- 00577804 PMS-ISONIAZID PMS
PYRAZINAMIDE
- 500MG Tablet
- 00618810 PMS-PYRAZINAMIDE PMS
- 00283991 TEBRAZID VAE
RIFABUTIN
- 150MG Capsule
- 02063786 MYCOBUTIN PFI
RIFAMPIN
- 150MG Capsule
- 02091887 RIFADIN SAC
- 00393444 ROFACT VAE
- 300MG Capsule
- 02092808 RIFADIN SAC
- 00210463 RIMACTANE NVR
- 00343617 ROFACT VAE
08:18.04 ADAMANTANES
AMANTADINE HCL
- 100MG Capsule
- 02130963 DOM-AMANTADINE DPC
- 02034468 ENDANTADINE LIN
- 02139200 GEN-AMANTADINE GEN
- 02199289 MED-AMANTADINE MEC
- 01990403 PMS-AMANTADINE PMS
- 10MG/ML Syrup
- 02130971 DOM-AMANTADINE DPC
- 02022826 PMS-AMANTADINE PMS
- 01913999 SYMMETREL BMS
08:18.08 ANTIRETROVIRALS
ABACAVIR
- 20MG/ML Oral Liquid
- 02240358 ZIAGEN GSK
- 300MG Tablet
- 02240357 ZIAGEN GSK
ABACAVIR, LAMIVUDINE
- 600MG & 300MG Tablet
- 02269341 KIVEXA GSK
ABACAVIR, LAMIVUDINE, ZIDOVUDINE
- 300MG & 150MG & 300MG Tablet
- 02244757 TRIZIVIR GSK
AMPRENAVIR
Limited use benefit (prior approval required).
For the management of HIV disease in patients who have failed other protease
inhibitor combinations, or for patients who experienced a lack of tolerability
to other protease inhibitors.
- 50MG Capsule
- 02243541 AGENERASE GSK
- 150MG Capsule
- 02243542 AGENERASE GSK
- 15MG/ML Oral Liquid
- 02243543 AGENERASE GSK
ATAZANAVIR SULFATE
- 150MG Capsule
- 02248610 REYATAZ BMS
- 200MG Capsule
- 02248611 REYATAZ BMS
- 300MG Capsule
- 02294176 REYATAZ BMS
DARUNAVIR
Limited use benefit (prior approval required).
For the management of HIV in patients who failed or have experienced adverse
events to three or more listed protease inhibitors.
- 300MG Tablet
- 02284057 PREZISTA JNO
DIDANOSINE
- 125MG Capsule
- 02244596 VIDEX
EC BMS
- 200MG Capsule
- 02244597 VIDEX
EC BMS
- 250MG Capsule
- 02244598 VIDEX
EC BMS
- 400MG Capsule
- 02244599 VIDEX
EC BMS
EFAVIRENZ
- 50MG Capsule
- 02239886 SUSTIVA BMS
- 100MG Capsule
- 02239887 SUSTIVA BMS
- 200MG Capsule
- 02239888 SUSTIVA BMS
- 600MG Tablet
- 02246045 SUSTIVA BMS
EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Limited use benefit (prior approval required).
For the treatment of HIV-1 infection adults where the virus is susceptible to each of tenofovir, emtricitabine and efavirenz, and:
- Atripla is used to replace existing therapy with its component drugs, or
- the patient is treatment naïve, or
- the patient has established viral suppression but requires antiretroviral therapy modification due to intolerance or adverse effects.
Note: Criteria will be confirmed against medication history.
- 600MG/200MG/300MG Tablet
- 02300699 ATRIPLA BMS
EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Limited use benefit (prior approval required).
For the treatment of patients with HIV infection where the virus is susceptible to both emtricitabine and tenofovir AND where the triple-entity antiretroviral agent (tenofovir/ emtricitabine/efavirenz) is not indicated due to one of the following:
- efavirenz resistance;
- adverse effects secondary to efavirenz.
- 200MG/300MG Tablet
- 02274906 TRUVADA GIL
FOSAMPRENAVIR CALCIUM
- 50MG/ML Oral Suspension
- 02261553 TELZIR GSK
- 700MG Tablet
- 02261545 TELZIR GSK
INDINAVIR SULFATE
- 200MG Capsule
- 02229161 CRIXIVAN FRS
- 400MG Capsule
- 02229196 CRIXIVAN FRS
LAMIVUDINE
- 10MG/ML Solution
- 02192691 3TC GSK
- 100MG Tablet
- 02239193 HEPTOVIR GSK
- 150MG Tablet
- 02192683 3TC GSK
- 300MG Tablet
- 02247825 3TC GSK
LAMIVUDINE, ZIDOVUDINE
- 150MG & 300MG Tablet
- 02239213 COMBIVIR GSK
LOPINAVIR, RITONAVIR
- 80MG & 20MG/ML Oral Solution
- 02243644 KALETRA ABB
- 100MG & 25MG Tablet
- 02312301 KALETRA ABB
- 200MG & 50MG Tablet
- 02285533 KALETRA ABB
NELFINAVIR MESYLATE
- 50MG/G Powder for Suspension
- 02238618 VIRACEPT PFI
- 250MG Tablet
- 02238617 VIRACEPT PFI
- 625MG Tablet
- 02248761 VIRACEPT PFI
NEVIRAPINE
- 200MG Tablet
- 02238748 VIRAMUNE BOE
RALTEGRAVIR
Limited use benefit (prior approval required).
For the treatment of HIV infection in patients who are antiretroviral experienced and have virologic failure due to resistance to at least one agent from each of the three major classes of antiretroviral agents, nucleoside/tide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors and protease inhibitors.
- 400MG Tablet
- 02301881 ISENTRESS FRS
RITONAVIR
- 100MG Capsule
- 02241480 NORVIR
SEC ABB
- 80MG/ML Liquid
- 02229145 NORVIR ABB
SAQUINAVIR MESYLATE
- 200MG Capsule
- 02216965 INVIRASE HLR
- 500MG Tablet
- 02279320 INVIRASE HLR
STAVUDINE
- 15MG Capsule
- 02216086 ZERIT BMS
- 20MG Capsule
- 02216094 ZERIT BMS
- 30MG Capsule
- 02216108 ZERIT BMS
- 40MG Capsule
- 02216116 ZERIT BMS
TENOFOVIR DISOPROXIL FUMARATE
Limited use benefit (prior approval required).
For the management of HIV disease in patients who have failed or have experienced
adverse events to an alternative nucleoside reverse transcriptase inhibitor.
- 245MG Tablet
- 02247128 VIREAD GIL
TIPRANAVIR
Limited use benefit (prior approval required).
For the management of HIV disease in patients
- who have failed all currently listed protease inhibitors
- intolerant to all currently listed protease inhibitors
- 250MG Capsule
- 02273322 APTIVUS BOE
ZIDOVUDINE
- 100MG Capsule
- 01946323 APO-ZIDOVUDINE APX
- 01902660 RETROVIR GSK
- 10MG/ML Syrup
- 01902652 RETROVIR GSK
08:18.20 INTERFERONS
PEGINTERFERON ALFA-2A
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve,
upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved.
A further 24 week supply may be approved if patient has a viral reduction of
at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will
be approved. Renewals will not be covered
- 180MCG/0.5ML Injection
- 02248077 PEGASYS HLR
- 180MCG/1ML Injection
- 02248078 PEGASYS HLR
PEGINTERFERON ALFA-2A, RIBAVIRIN
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve,
upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved.
A further 24 week supply may be approved if patient has a viral reduction of
at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will
be approved. Renewals will not be covered
- 180MCG/0.5ML & 200MG Injection & Tablet
- 02253429 PEGASYS
RBV HLR
- 180MCG/1ML & 200MG Injection & Tablet
- 02253410 PEGASYS
RBV HLR
PEGINTERFERON ALFA-2B
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve,
upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved.
A further 24 week supply may be approved if patient has a viral reduction of
at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will
be approved. Renewals will not be covered
- 74MCG/VIAL Injection
- 02242966 UNITRON
PEG SCH
- 118.4MCG/VIAL Injection
- 02242967 UNITRON
PEG SCH
- 177.6MCG/VIAL Injection
- 02242968 UNITRON
PEG SCH
- 222MCG/VIAL Injection
- 02242969 UNITRON
PEG SCH
PEGINTERFERON ALFA-2B, RIBAVIRIN
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis C in patients who are treatment naïve,
upon the written request of a hepatologist or other specialist in this area.
- For genotypes 1, 4, 5 and 6, an initial 24 week supply will be approved.
A further 24 week supply may be approved if patient has a viral reduction of
at least 2 logs or HCV is undetectable at 12 weeks (48 weeks total).
- For genotypes 2 or 3, initial coverage for a maximum of 24 weeks will
be approved. Renewals will not be covered
- 50MCG/0.5ML & 200MG Injection & Capsule
- 02246026 PEGETRON SCH
- 02254573 PEGETRON
REDIPEN SCH
- 80MCG/0.5ML & 200MG Injection & Capsule
- 02246027 PEGETRON SCH
- 02254581 PEGETRON
REDIPEN SCH
- 100MCG/0.5ML & 200MG Injection & Capsule
- 02246028 PEGETRON SCH
- 02254603 PEGETRON
REDIPEN SCH
- 120MCG/0.5ML & 200MG Injection & Capsule
- 02246029 PEGETRON SCH
- 02254638 PEGETRON
REDIPEN SCH
- 150MCG/0.5ML & 200MG Injection & Capsule
- 02246030 PEGETRON SCH
- 02254646 PEGETRON
REDIPEN SCH
08:18.32 NUCLEOSIDES AND NUCLEOTIDES
ACYCLOVIR
- 40MG/ML Suspension
- 00886157 ZOVIRAX GSK
- 200MG Tablet
- 02207621 APO-ACYCLOVIR APX
- 02242784 GEN-ACYCLOVIR GEN
- 02285959 NOVO-ACYCLOVIR NOP
- 02197405 NU-ACYCLOVIR NXP
- 02237541 PDL-ACYCLOVIR PDL
- 02078627 RATIO-ACYCLOVIR RPH
- 00634506 ZOVIRAX GSK
- 400MG Tablet
- 02207648 APO-ACYCLOVIR APX
- 02242463 GEN-ACYCLOVIR GEN
- 02285967 NOVO-ACYCLOVIR NOP
- 02197413 NU-ACYCLOVIR NXP
- 02237542 PDL-ACYCLOVIR PDL
- 02078635 RATIO-ACYCLOVIR RPH
- 01911627 ZOVIRAX GSK
- 800MG Tablet
- 02207656 APO-ACYCLOVIR APX
- 02242464 GEN-ACYCLOVIR GEN
- 02285975 NOVO-ACYCLOVIR NOP
- 02197421 NU-ACYCLOVIR NXP
- 02237543 PDL-ACYCLOVIR PDL
- 02078651 RATIO-ACYCLOVIR RPH
- 01911635 ZOVIRAX GSK
ADEFOVIR DIPIVOXIL
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis B infection when used in combination with lamivudine in patients who have developed failure to lamivudine, as defined by an increase in HBV DNA of ≥ 1 log10 IU/mL above the nadir, measured on two separate occasions within an interval of at least one month, after the first three months of lamivudine therapy, and when failure to lamivudine is not due to poor adherence to therapy.
- 10MG Tablet
- 02247823 HEPSERA GIL
ENTECAVIR
Limited use benefit (prior approval required).
For the treatment of chronic hepatitis B infection in patients with cirrhosis documented on radiologic or histologic grounds and a HBV DNA concentration above 2000IU/mL.
- 0.5MG Tablet
- 02282224 BARACLUDE BMS
FAMCICLOVIR
- 125MG Tablet
- 02292025 APO-FAMCICLOVIR APX
- 02305682 CO FAMCICLOVIR COB
- 02229110 FAMVIR NVR
- 02278081 PMS-FAMCICLOVIR PMS
- 02278634 SANDOZ-FAMCICLOVIR SDZ
- 250MG Tablet
- 02292041 APO-FAMCICLOVIR APX
- 02305690 CO FAMCICLOVIR COB
- 02229129 FAMVIR NVR
- 02278103 PMS-FAMCICLOVIR PMS
- 02278642 SANDOZ-FAMCICLOVIR SDZ
- 500MG Tablet
- 02292068 APO-FAMCICLOVIR APX
- 02305704 CO FAMCICLOVIR COB
- 02177102 FAMVIR NVR
- 02278111 PMS-FAMCICLOVIR PMS
- 02278650 SANDOZ-FAMCICLOVIR SDZ
GANCICLOVIR SODIUM
- 500MG Injection
- 02162695 CYTOVENE HLR
VALACYCLOVIR HCL
- 500MG Tablet
- 02295822 APO-VALACYCLOVIR APX
- 02298457 PMS-VALACYCLOVIR PMS
- 02316447 RIVA-VALACYCLOVIR RIV
- 02219492 VALTREX GSK
VALGANCICLOVIR HCL
- 450MG Tablet
- 02245777 VALCYTE HLR
08:30.04 AMEBICIDES
DIIODOHYDROXYQUIN
- 210MG Tablet
- 01997769 DIODOQUIN GLE
- 650MG Tablet
- 01997750 DIODOQUIN GLE
PAROMOMYCIN SULFATE
- 250MG Capsule
- 02078759 HUMATIN ERF
08:30.08 ANTIMALARIALS
CHLOROQUINE PHOSPHATE
- 250MG Tablet
- 00021261 NOVO-CHLOROQUINE NOP
HYDROXYCHLOROQUINE SULFATE
- 200MG Tablet
- 02246691 APO-HYDROXYQUINE APX
- 02252600 GEN-HYDROXYCHLOROQUINE GEN
- 02017709 PLAQUENIL SAC
- 02311011 PRO-HYDROXYQUINE PDL
PRIMAQUINE PHOSPHATE
- 26.3MG Tablet
- 02017776 PRIMAQUINE SAC
PYRIMETHAMINE
- 25MG Tablet
- 00004774 DARAPRIM GSK
08:30.92 MISCELLANEOUS ANTIPROTOZOALS
ATOVAQUONE
- 150MG/ML Suspension
- 02217422 MEPRON GSK
METRONIDAZOLE
- 500MG Capsule
- 02248562 APO-METRONIDAZOLE APX
- 00783137 TRIKACIDE PMS
- 250MG Tablet
- 00545066 APO-METRONIDAZOLE APX
- 00420409 METRONIDAZOLE PDL
PENTAMIDINE ISETHIONATE
- 300MG/VIAL Injection
- 02183080 PENTAMIDINE MAY
TRIMETREXATE GLUCURONATE
- 25MG/VIAL Injection
- 02065770 NEUTREXIN MIO
08:36.00 URINARY ANTI-INFECTIVES
NITROFURANTOIN
- 50MG Capsule
- 01997637 MACRODANTIN PGP
- 02231015 NOVO-FURANTOIN NOP
- 100MG Capsule
- 02063662 MACROBID PGP
- 02231016 NOVO-FURANTOIN NOP
- 50MG Tablet
- 00319511 APO-NITROFURANTOIN APX
- 100MG Tablet
- 00312738 APO-NITROFURANTOIN APX
TRIMETHOPRIM
- 100MG Tablet
- 02243116 APO-TRIMETHOPRIM APX
- 200MG Tablet
- 02243117 APO-TRIMETHOPRIM APX